BioWorld

June 15, 2000

View Archived Issues

Inhibitex Raises $15M In Series C To Finance Antibiotic Candidates

Read More

Other News To Note

Read More

Modex Signs Deal With Novartis, Plans IPO On Swiss Exchange

Read More

House Drug Plan Met With Skepticism From Both Sides

Read More

EntreMed Raises $22M For Its Lead Cancer Drug Candidates

Read More

EyeTech Attracts $34M In Start-Up Financing Round

Read More